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http://www.ehjournal.net/content/12/1/105RESEARCH Open AccessTraffic-related exposures and biomarkers of
systemic inflammation, endothelial activation and
oxidative stress: a panel study in the US trucking
industry
Andreas M Neophytou1*, Jaime E Hart1,2, Jennifer M Cavallari1,3, Thomas J Smith1, Douglas W Dockery1,
Brent A Coull4, Eric Garshick2,5 and Francine Laden1,2Abstract
Background: Experimental evidence suggests that inhaled particles from vehicle exhaust have systemic effects on
inflammation, endothelial activation and oxidative stress. In the present study we assess the relationships of
short-term exposures with inflammatory endothelial activation and oxidative stress biomarker levels in a population
of trucking industry workers.
Methods: Blood and urine samples were collected pre and post-shift, at the beginning and end of a workweek
from 67 male non-smoking US trucking industry workers. Concurrent measurements of microenvironment
concentrations of elemental and organic carbon (EC & OC), and fine particulate matter (PM2.5) combined with time
activity patterns allowed for calculation of individual exposures. Associations between daily and first and last-day
average levels of exposures and repeated measures of intercellular and vascular cell adhesion molecule-1 (ICAM-1 &
VCAM-1), interleukin 6 (IL-6) and C-reactive protein (CRP) blood levels and urinary 8-Hydroxy-2′-Deoxyguanosine
(8-OHdG) were assessed using linear mixed effects models for repeated measures.
Results: There was a statistically significant association between first and last-day average PM2.5 and 8-OHdG
(21% increase, 95% CI: 2, 42%) and first and last-day average OC and IL-6 levels (18% increase 95% CI: 1, 37%)
per IQR in exposure. There were no significant findings associated with EC or associations suggesting acute
cross-shift effects.
Conclusion: Our findings suggest associations between weekly average exposures of PM2.5 on markers of oxidative
stress and OC on IL-6 levels.
Keywords: Particulate matter, Elemental carbon, Organic carbon, ICAM-1, VCAM-1, IL-6, CRP, Inflammation, Endothelial
activation, Trucking industryBackground
Vehicle exhaust related particulate air pollution has been
associated with cardiovascular health outcomes, includ-
ing, ventricular arrhythmias, onset of myocardial infarc-
tion and increased cardiovascular mortality [1-7], while
occupational exposures to vehicle exhaust also have been
shown to be associated with ischemic heart disease [8,9].* Correspondence: aneophyt@hsph.harvard.edu
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Creative Commons Attribution License (http:/
distribution, and reproduction in any mediumWe have previously observed an increased risk of ischemic
heart disease mortality in US trucking industry workers
with regular exposures to exhaust from diesel, gasoline
and propane source [10]. Occupational air pollution expo-
sures in the trucking industry are relevant to the general
population due to overlap with levels experienced during
daily activities such as commuting [11,12].
Potential pathways for these outcomes include systemic
inflammation, endothelial dysfunction and oxidative stress,
which experimental animal and human studies suggest are
associated with traffic-related particulate matter (PM)tral Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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and induction of inflammatory responses and oxidative
stress, however, are not adequately defined and have not
been well characterized in a population with vehicle
exhaust exposures in a non-experimental setting.
Previous studies have shown associations between bio-
markers of endothelial function such as transmembrane
proteins intercellular adhesion molecule-1 (ICAM-1)
and vascular cell adhesion molecule-1 (VCAM-1), and
air pollution exposures [21]. ICAM-1 and VCAM-1
levels are associated with increased cardiovascular risk
and are predictors of acute coronary events [22-24].
General markers of inflammation like interleukin-6
(IL-6) and C-reactive protein (CRP) have also been
associated with cardiovascular risk [25,26] and air
pollution [27,28]. In addition, CRP has recently been
linked to cancer mortality in general and lung cancer
incidence in particular [29,30]. Urinary 8-Hydroxy-2′-
Deoxyguanosine (8-OHdg) is a DNA lesion repair product
[31], suitable as an oxidative damage biomarker that has
also been shown to be associated with particulate expo-
sures [15,32,33].
The current study characterizes exposures to differ-
ent components of engine exhaust in a sample of
workers in the trucking industry and examines the
relation between exposure and inflammation, endothe-
lial activation, and oxidative stress as indicated by
plasma levels of IL-6, CRP, ICAM-1 and VCAM-1
and by urinary levels of 8-OHdG from repeated blood
and urine samples, sampled over the duration of one
work-week. The study examines associations over differ-
ent time-windows for both acute and more intermediate-
term effects.
Methods
Study population
We studied a sample of 95 workers originated from
10 work locations (truck terminals) in the northeastern
US (specifically CT, MA, MD, NJ, NY, and PA). Primary
analyses were restricted to non-smoking males with bio-
logical samples who did not report sick days during the
sampling period (n = 67). Measurements took place
between February 2009 and October 2010, with
terminals sampled one at time for up to 8 days of
continuous sampling. Subjects were selected from 3
different job categories representing different exposure
scenarios: pick-up and delivery (P&D) drivers, freight
dockworkers and office clerks. Participants provided
informed consent and were compensated at the end
of the protocol for their participation. The protocol
was approved by the Institutional Review Board of
the Brigham and Women’s Hospital and the Human
Subjects Committee of the Harvard School of Public
Health.Microenvironment exposure measurements
Microenvironment area samples of PM2.5 (particulate
matter with a diameter of ≤2.5 μm), as well as elemental
carbon (EC) and organic carbon (OC) in PM1.0 (particu-
late matter with a diameter of ≤1.0 μm) were collected
from all 10 terminals in the study. Twelve-hour integra-
tive area samples were collected indoors in office spaces
and terminal docks 24 hours a day. For the P&D drivers,
samplers were placed in their truck cabs for the duration
of each work-shift on the days of biological sample
collection. Detailed exposure assessment for each of the
three pollutants is described elsewhere [11]. Briefly EC
and OC were measured by collecting PM1.0 on a 22-mm
quartz tissue filter, preceded by a precision machined
cyclone separator (SCC1.062 Triplex, BGI, Inc., Waltham,
MA), which was then analyzed by thermal-optical carbon
analyzer using the NIOSH 5040 method [34]. PM2.5 was
collected on a 37-mm Teflon filter (with a pore diameter
of 2.0 μm) after passing through a precision-machined
cyclone pre-selector to remove particles greater than
2.5 μm aerodynamic diameter. The method was consistent
with the EPA PQ200 Federal Reference Method [35,36]. A
flow rate of 3.5 liters per minute was used for both PM2.5
and PM1.0 samples. Exposures were assigned to each
individual participant as a weighted average of the time
spent in each work location based on the samples in each
location during each work shift.
Biomarker sampling
During each truck terminal visit, initial blood samples
were drawn and urine was collected from study partici-
pants prior to the day’s work shift on their first day back
to work after at least 2 days off. At the end of the first
work shift a second blood and urine sample were
collected and then pre- and post-shift samples were
collected again on the last workday of the same week. At
each blood draw, two 10-ml liquid EDTA blood tubes
were drawn and stored at 4°C until shipped in an insu-
lated container to our blood processing laboratory where
they were centrifuged, aliquoted and stored in the vapor
phase of liquid nitrogen freezers at < −130°C. Up to
50 ml of urine were collected in a sterile urine cup at
each sampling period and stored at 4°C until returned to
the study laboratory, where they were kept at -20°C until
analysis.
Analysis of CRP, IL-6, ICAM-1 and VCAM-1 was
done at the Clinical and Epidemiologic Research Labora-
tory, Department of Laboratory Medicine at Children’s
Hospital in Boston, a state-of the-art laboratory spe-
cializing in micro-analysis. The stability of the selected
biomarkers was assessed by processing at 0, 24 and
36 hours after packaging and storage on ice in a
shipping container and there were no differences in the
measured marker levels [37].
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high sensitivity immonoturbidimetric assay, with a sensi-
tivity of 0.03 mg/L. Values of CRP > 10 mg/L (n = 3)
were excluded from the analysis as they suggest ele-
vation due to recent acute illness. IL-6, ICAM-1 and
VCAM-1 were measured using ELISA assays with sensi-
tivities of 0.094 pg/mL, 0.35 ng/mL and 0.6 ng/mL,
respectively. Urinary 8-OHdG levels were measured in
the laboratory of Dr. Junfeng Zhang at the University of
Southern California using a high performance liquid chro-
matography with electrochemical detection (HPLC-ECD)
method with a level of detection (LOD) of 0.46 ng/mL.
Urinary creatinine was also measured and 8-OHdG levels
were corrected and reported as μg/g creatinine. Three
subjects contributed no or insufficient blood sample
volumes for analysis on at least one measurement occa-
sion and analysis was restricted to the remaining occa-
sions for these individuals. None of the analyzed samples
were below the stated LODs.
Health and personal habit assessment
A baseline medical and health questionnaire based on
the American Thoracic Society adult respiratory ques-
tionnaire [38] was administered to all participants. The
questionnaire included standardized questions regarding
respiratory symptoms and conditions, and was supple-
mented with questions about other medical conditions
such as heart disease, cancer, and diabetes. Information
was also provided on job title and job history, date and
time of last work shift, past week work schedule, ter-
minal assignment, specific duties, recent acute illnesses,
and lifestyle characteristics such as physical activity and
smoking history. A personal habits portion of the ques-
tionnaire including medication use (such as aspirin,
blood pressure medications and lipid lowering agents),
smoking, and second hand smoke (SHS) exposure as
well as information on job duties during the day, and
timing and location of all breaks, was administered at
the end of each shift during the work week. Weight and
height were measured by the study team to calculate
body mass index (BMI).
Statistical analyses
Marker levels were natural log-transformed and propor-
tional changes are reported. Linear mixed effects models
for repeated measures with unstructured autocorellation,
were used to estimate the effects each of the measured
pollutants on marker levels for all study participants in
the primary analysis study population. We included a
random intercept for each participant to account for
baseline inter-individual differences. Personal charac-
teristics including known predictors of CRP, IL-6,
ICAM-1 and VCAM-1 such as age, BMI, physician diag-
nosed hypertension, physical activity, chronic disease,and medication use were included as confounders a
priori in the models. Models for 8-OHdG included age,
BMI, physical activity, diabetes, and chronic respiratory
conditions, which are thought to be associated with oxi-
dative damage [39,40]. Additional covariates such as ter-
minal (accounting for possible seasonal and regional
differences), past smoking history, self reported SHS ex-
posures during the work shift, and switching shifts were
also considered as potential confounders and were kept
in the models if they changed the primary effect estimate
by ≥10%. The models fitted were as follows:
Y ijk ¼ β0 þ β1 Expð Þi þ β2 dayð Þj þ β3 shiftð Þk
þ β4 day  shiftð Þjk þ γ covariatesð Þijk
þ bi þ εijk
where:
 Yijk: log-transformed marker levels for subject i, on
day j, at the k (pre-or post-shift) measurement point
 Expi: Entered as the first and last-day average of the
daily pollutant levels on the two measured work-
shifts
 Dayj: Measurement day j: first or last day worked
during the week
 Shiftk: Measurement time k relevant to shift: pre- or
post-shift
 Covariatesijk: Covariates entered in the model
depending on biomarker of interest as listed above.
 bi: random intercept for each individual i
 εijk: within subject error
The average exposure model was fitted to examine
possible effects that persist rather than being acute. The
day and shift variables and their interaction allow out-
come measurements to vary with time irrespective of
exposure or covariate values. To examine for any transient
effects the following model was fitted:
Y ij ¼ β0 þ β1 Expð Þij þ β2 dayð Þj þ γ covariatesð Þij
þ bi þ εij
Using only post-shift measurements where Expij is the
estimated daily exposure for each participant on a given
day, and the other variables are as described above.
In the case of statistically significant findings, multi-
pollutant models were fitted. Models with penalized
spline terms instead of linear terms for exposures were
fitted to examine the shape of dose-responses. Finally,
exposure time (day and shift) interactions were also in-
cluded and the choice of the final model was decided by
likelihood ratio tests. Statistical analysis was performed
using the SAS mixed procedure (SAS version 9.3; SAS
Institute Inc., Cary, NC) and penalized spline models
were fitted using the R mgcv package (R, version 2.15.2).
Table 1 Study population baseline characteristics in a sample of male, non-smoking trucking industry workers
Total P&D driver Dock Office
Total no. 67 35 14 18
Race (no. (%))
White 62 (93%) 32 (91%) 14 (100%) 16 (89%)
Hispanic 5 (7%) 3 (9%) 0 (0%) 2 (11%)
Age (years, mean ± SD) 50.4 ± 8.5 51.1 ± 7.8 47.9 ± 11.0 50.8 ± 7.5
BMI (kg/m2, mean ± SD) 30.4 ± 4.4 30.8 ± 4.1 29.8 ± 4.3 30.1 ± 5.2
Past smoker (no. (%)) 36 (54%) 23 (66%) 6 (43%) 7 (39%)
Exercise (hrs/wk, mean ± SD) 3.3 ± 3.7 2.3 ± 2.9 4.6 ± 5.4 4.4 ± 2.7
Hypertension (no. (%)) 24 (36%) 13 (37%) 6 (43%) 5 (28%)
Heart disease (no. (%)) 3 (4%) 0 (0%) 1 (7%) 2 (11%)
CHD (no. (%)) 6 (9%) 4 (11%) 1 (7%) 1 (6%)
Diabetes (no. (%)) 1 (1.5%) 1 (3%) 0 (0%) 0 (0%)
Medication use
Blood pressure 19 (28%) 9 (26%) 5 (36%) 5 (28%)
Lipid lowering 24 (36%) 14 (40%) 4 (29%) 6 (33%)
Aspirin 17 (25%) 9 (26%) 2 (14%) 6 (33%)
Total workdays (mean ± SD) 4.0 ± 0.5 3.9 ± 0.4 4.4 ± 0.5 3.9 ± 0.5
Avg shift duration (hrs, mean ± SD) 9.5 ± 1.8 10.6 ± 1.0 8.6 ± 1.6 8.1 ± 1.9
Total hrs worked during study period 45.8 ± 9.4 50.7 ± 6.9 41.7 ± 9.3 39.3 ± 8.8
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Figure 1 Boxplots for first and last-day average exposure levels. PM2.5, EC, OC levels by job title and all job-titles combined. The outer box
lines represent the first and third quartiles, while the thick horizontal line in the box represents the median. The “whiskers” extend to the values
of the sample within 1.5 IQR of the lower and upper quartiles, and values outside this range are represented as circles.
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Study population
Descriptive statistics for the participants in the primary
analysis are presented in Table 1 collectively and by job
title. Briefly, the study sample was predominantly white
(93%), while the age range was 23 to 66 years, with a
mean ± standard deviation (SD) of 50.4 ± 8.5. The range
for the length of the workweek among study participants
was 2 to 5 days with a mean of 4 days. The range of shift
length was 2.2 to 13.4 hours with a mean of 9.5 hours
per shift and an average of 45.8 hours worked during the
week, with drivers working longer hours that the other
two job groups. Overall this was a healthy working
population except for elevated BMI levels (mean BMI
was 30.4 ± 4.4), with few reports of chronic disease.
Twenty-four (36%) participants reported use of lipid
lowering agents and nineteen (28%) reported use of
blood pressure medication. Study participants appeared
to be similar across job titles with the exceptions that15
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Figure 2 Boxplots for endothelial activation, inflammation, and oxida
measurement occasions used for each participant, shown for by job title anP&D Drivers were more likely to be ex-smokers. One-
Way Analysis of Variance indicated significant differ-
ences across job title levels in only the means of length
of work week and total hours worked out of all covari-
ates presented (p-value for F-test <0.01 for both).
Exposure measurements
Estimated individual exposure levels are presented in
Figure 1. Overall first-and-last-day average (± SD) levels
for the three pollutants examined were 10.22 (± 4.30)
μg/m3 for PM2.5, 0.54 (± 0.40) μg/m
3 for EC and 8.60
(± 2.91) μg/m3 for OC. Dockworkers and P&D drivers
had higher PM2.5 and EC exposures compared to office
clerks, while OC was highest among P&D drivers
followed by office clerks. Correlations between average
exposures were not high with pearson coefficients of
0.370 between PM2.5 and EC, 0.344 between PM2.5 and
EC, and 0.004 between EC and OC. One-Way Analysis
of Variance indicated significant differences for the50
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tive stress biomarker levels. Average levels from the four
d all job-titles combined.
Table 2 Mean (± SD) and geometric mean (± GSD) for subject specific mean marker levels averaged over the 4 different
measurement points
Biomarker Overall P&D drivers Dockworkers Office clerks
Mean (±SD) GM (±GSD) Mean (±SD) GM (±GSD) Mean (±SD) GM (±GSD) Mean (±SD) GM (±GSD)
ICAM-1 (ng/mL) 202 ± 40 198 ± 1.22 208 ± 42 203 ± 1.23 216 ± 34 213 ± 1.17 181 ± 32 178 ± 1.19
VCAM-1 (ng/mL) 677 ± 131 661 ± 1.21 679 ± 144 663 ± 1.23 673 ± 123 658 ± 1.21 675 ± 115 661 ± 1.19
IL-6 (pg/mL) 1.38 ± 1.20 1.09 ± 1.71 1.36 ± 0.79 1.12 ± 1.59 1.50 ± 2.17 0.98 ± 2.14 1.30 ± 0.82 1.11 ± 1.61
CRP (mg/L) 1.66 ± 1.80 1.00 ± 2.63 1.53 ± 1.51 1.01 ± 2.36 1.72 ± 1.68 0.98 ± 3.18 1.87 ± 2.41 1.01 ± 2.90
8-OHdG (μg/g creat.) 55.9 ± 31.5 47.7 ± 1.79 58.9 ± 32.9 49.3 ± 1.90 52.8 ± 36.1 45.8 ± 1.67 52.3 ± 25.4 46.0 ± 1.72
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levels (p-value for F-test <0.001 for all three pollutants).
Associations between biomarker levels and exposures
From the 67 participants, a total of 264 blood (ICAM-1,
VCAM-1, IL-6, CRP) and 268 urine samples (8-OHdG)
were analyzed. The distributions of subject specific mean
biomarker levels are shown in Figure 2, while mean (± SD),
medians, geometric means (GM) and geometric standard
deviations (GSD) are summarized in Table 2 (Presented
here as the average of four collection time points for des-
criptive purposes; biomarker measurements were entered
individually in all models considered). For the endothelial
activation markers, there was little difference in the means
by job title for VCAM-1, but mean ICAM-1 levels were
higher among P&D drivers and dockworkers compared to
office clerks (p-value for One-Way Analysis of Variance
F-Test, p = 0.03). However, neither ICAM-1 nor VCAM-
1, were associated with PM2.5, EC, and OC levels for either
the average (Table 3) or daily shift exposures (Table 4).
Little difference was seen in inflammation (CRP, IL-6)
biomarker levels across job titles (Table 2). No associa-
tions with any of the pollutant exposures were seen for
CRP, but a statistically significant association between
IL-6 and first and last-day average OC levels was obser-
ved (17.7% increase per IQR in exposure, 95% CI: 1.2,
36.9%) (Table 3). The OC effect size (18.7%, 95% CI: 0.7,
39.8%) was stable in the multi-pollutant model, where
first and last-day average PM2.5 and EC were included at
the same time (Table 5). No significant associations were
observed between any of the daily exposures and inflam-
mation marker levels (Table 4).Table 3 Percent change and 95% confidence intervals in biom
exposure levelsa
Exposureb IQR ICAM-1 VCAM-1
PM2.5 4.59 3.5 (−1.1, 8.4) 0.4 (−4.3, 5.4)
EC 0.51 −1.2 (−6.8, 4.6) −1.7 (−7.4, 4.3)
OC 3.62 −2.2 (−7.8, 3.8) 2.4 (−3.6, 8.9)
Notes: aLinear mixed effect models for repeated measures using all 4 measurement
age, BMI, physical activity, hypertension, chronic disease, SHS exposure and in the c
medication use.
bPollutant models with first and last-day average exposure values (average of availa
pollutant modelled separately.Mean 8-OHdG levels were similar among all job titles
(Table 2). However, there was a statistically significant
increase in 8-OHdG levels associated with each IQR in-
crease in first and last-day average PM2.5 (20.6%, 95% CI:
2.4, 42.0%) (Table 3). The PM2.5 effect size (16.7%, 95%
CI: -3.3, 40.9%) remained elevated though not statis-
tically significant in the model that included all three
pollutants (Table 5). Again, no significant associations
were observed between any of the daily exposures and
8-OHdG (Table 4).
No exposure time interactions were statistically signifi-
cant; therefore, they were not included in the primary
models for any of the biomarkers considered. The final
models also included all covariates that were added a
priori and self reported SHS exposure. Penalized spline
models (Figure 3) indicated that there were no statisti-
cally significant deviations from linearity.
Discussion
Overall our findings suggest average (calculated as the
mean of two measurement days) but not daily effects of
traffic related exposures on biomarkers of oxidative
stress and inflammation. Specifically, we observed a
statistically significant association between average PM2.5
levels and urine levels of the oxidative damage marker
8-OHdG. Although exposure data were not available for
all work shifts during the complete work-week, this
finding was consistent in direction and magnitude with
reported increases of 8-OHdG associated with a 7-day
moving average of ambient PM2.5 levels in an elderly
population [15]. The same study reports an even greater
increase with 21-day moving averages indicating aarker levels associated with each IQR increase in average
IL-6 CRP 8-OHdG
3.3 (−8.6, 16.7) −6.3 (−25.1, 17.3) 20.6 (2.4, 42.0)
−3.1 (−16.7, 12.8) −15.0 (−35.6, 12.2) 17.5 (−4.6, 44.7)
17.7 (1.2, 36.9) 4.1 (−21.9, 38.8) 10.4 (−11.3, 37.4)
s per participant, with random intercepts for each individual and adjusting for
ase of inflammation and endothelial activation markers time varying
ble daily exposures over the work-week) as the exposure of interest, with each
Table 4 Percent change and 95% confidence intervals in biomarker levels associated with each IQR increase in daily
exposure levelsa
Exposureb IQR ICAM-1 VCAM-1 IL-6 CRP 8-OHdG
PM2.5 6.11 −1.1 (−3.7, 1.5) −1.8 (−4.2, 0.7) 2.2 (−7.6, 13.0) −0.2 (−13.1, 14.8) 8.9 (−6.5, 26.5)
EC 0.56 0.1 (−2.5, 2.8) −0.3 (−2.8, 2.3) −7.1 (−14.6, 1.0) −5.3 (−13.7, 4.0) 4.9 (−9.3, 21.3)
OC 3.97 −1.1 (−4.4, 2.2) −1.1 (−4.3, 2.1) 12.2 (−0.4, 25.8) 1.2 (−14.7, 20.0) −3.1 (−18.7, 15.4)
Notes: aLinear mixed effect models for repeated measures using only the 2 post-shift measurements per participant, with random intercepts for each individual
and adjusting for age, BMI, physical activity, hypertension, chronic disease, SHS exposure and in the case of inflammation and endothelial activation markers time
varying medication use.
bPollutant models with daily exposure values as the exposure of interest, with each pollutant modelled separately.
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OC, but not for EC. In our study, effect estimates for
EC and OC were also positive, but not statistically
significant.
We observed a statistically significant increase in IL-6
associated with average OC, but not with other air pollu-
tant measures. This association remained statistically
significant even after controlling for other pollutants.
Three and five-day moving averages of primary OC in
PM exposure effects on IL-6 blood levels in elderly sus-
ceptible populations have also been reported in previous
studies and appeared more pronounced than 1-day
moving average exposures [41]. This would suggest a
more gradual inflammatory response as compared to an
acute effect. While the study populations may not be
necessarily comparable, in our study, neither the effect
estimates for daily exposures nor any exposure-time
interactions were statistically significant, which may be a
further indication that any exposure effects may accu-
mulate over longer time windows than were assessed
here. Given that this a chronically exposed population, it
is possible that there is a longer lasting effect on bio-
marker levels and no apparent washout over the space
of two days off work. Unfortunately in the present study,
we lacked the data to be able to address this issue.
A number of general population studies have not
shown relationships between air pollution and inflam-
matory markers. Specifically, studies examining PM and
CRP and IL-6 levels in healthy individuals saw no signifi-
cant associations [42-44]. There is evidence; however, ofTable 5 Percent change and 95% confidence intervals of
IL-6 and 8-OHdG levels associated in multi-exposure
models of first and last-day average exposuresa
Exposureb IL-6 8-OHdG
PM2.5 −0.6 (−13.4, 14.0) 16.7 (−3.3, 40.9)
EC −4.4 (−18.3, 11.9) 9.1 (−12.4, 36.0)
OC 18.7 (0.7, 39.8) 2.2 (−18.5, 28.2)
Notes: aLinear mixed effect models for repeated measures using all 4
measurements per participant, with random intercepts for each individual and
adjusting for age, BMI, physical activity, hypertension, chronic disease, SHS
exposure and in the case of IL-6 time varying medication use.
bModels included first and last-day-average values for PM2.5, EC and OC in the
same model.greater susceptibility in certain individuals such as those
with coronary heart disease or diabetes [28,42]. CRP
levels measured 10-14 hr after the work-shift in North
Carolina State Troopers studied over 4-days, were asso-
ciated with PM2.5 levels in their patrol cars [45], but to
our knowledge those results have not been reproduced.
Overall findings on the association between CRP and
PM exposures in particular have been mixed with a
number of studies, including randomized crossover
trials, reporting no significant associations between PM
concentrations and CRP levels [46].
Our results concerning endothelial activation (ICAM-1
and VCAM-1) did not yield any statistically significant
findings. Modest increases associated with ambient PM2.5
have been reported for these markers in an elderly popu-
lation, again more pronounced when 7-day or longer
moving averages of exposure were considered compared
to shorter periods [47]; however, our study was not
designed to detect associations with averaging periods of
that length. Previous studies have also shown acute in-
creases in ICAM-1 and VCAM-1 in bronchial tissue and
mucosa in healthy volunteers exposed to diesel particles
in experimental settings, but at much higher exposure
levels than the ones observed in this study. Furthermore,
those volunteers were not chronically exposed [17,48].
Associations between VCAM-1 levels and 2-day average
black carbon (BC) exposures have also been reported
[49], as well as between longer BC exposure averages
(4–12 weeks) and ICAM-1 [21], and lastly 1–2 day
lagged associations between EC and ICAM-1 in coronary
heart disease patients [16]. We found no evidence of
associations between EC and these endothelial activation
markers in our time windows.
Trucking industry and highway exposures have de-
creased in recent years, as a result of recent emissions
regulations [50]. The low levels of exposures observed in
the current study may have been a reason for the lack of
additional significant findings. Another limitation of this
study is that the sampling scheme limited biological
samples and exposure measurements to two days in the
space of one week, so exposure windows greater than
one week and lagged daily exposure effects could not be
examined. Our reliance on microenvironmental samples,
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Figure 3 Exposure-response penalized spline term graphs. Associations between OC first and last-day average levels and IL-6 (left, effective
degrees of freedom (edf) = 1, p = 0.01) and PM2.5 first and last-day average levels and 8-OHdG (right, edf = 1.4, p = 0.02). Models adjusted for age, BMI,
physical activity, hypertension, chronic disease, SHS exposure and in the case of IL-6 time varying medication use. (Dashed lines denote 95% CIs).
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http://www.ehjournal.net/content/12/1/105instead of personal samplers for each worker for each
shift also likely lead to increased exposure misclassifica-
tion. We also lacked information on exposures prior and
between the shifts sampled. Exposures throughout the
work week were not available for a significant portion of
the study participants so average exposures over the
entire week could not be considered. Additional limita-
tions include limited power to detect modest effect sizes
given the final sample size of non-smoking participants,
number of measurements, and limited variability in
exposures. Biomarker levels were measured with state of
the art and highly sensitive methods. Pre- and post-shift
samples were collected on the same time on the two
sampling days, and statistical models included terms for
time allowing variation but may not entirely capture
within-person variation and diurnal patterns for these
markers. Some non-differential misclassification may be
expected, and could further reduce power to detect
associations between an outcome and the exposures.
Additionally, the study population is a generally healthy
working male population so the findings may not be
applicable to more sensitive or susceptible populations
or to females.
The main strength of the current study was the con-
current assessment of microenvironment exposures and
biomarker sampling in a study population with regular
exposure to freshly generated exhaust, in levels that
overlap with those seen in the general population. All
sampled terminals were in the same company, with
identical control technologies and al trucks were less
than 5 years old, thus excluding potential sources of
differential exposure misclassification across terminals.
Additionally, we have previously shown that our
microenvironment as defined by job description and
location within a trucking terminal are highly repre-
sentative of measured personal exposures in this in-
dustry [51].Conclusion
Our findings suggest associations of a first and last
workday average, but not daily occupational traffic
related exposures with biomarkers of inflammation and
oxidative stress. There was also evidence of different
effects of separate components of PM on different
biomarkers, specifically a PM2.5 effect on oxidative stress
marker levels and an OC effect on inflammation marker
IL-6 levels, indicating that different PM components
may affect different biologic pathways.
Abbreviations
EC: Elemental carbon; OC: Organic carbon; PM2.5: Particulate matter less than
2.5 μm in diameter; ICAM-1: Intercellular adhesion molecule 1; VCAM-
1: Vascular cell adhesion molecule 1; IL-6: Interleukin 6; CRP: C-reactive
protein; 8-OHdG: 8-Hydroxy-2′-Deoxyguanosine; IQR: Interquartile range;
PM: Particulate matter; P&D: Pick-up and delivery; PM1.0: Particulate matter
less than 1.0 μm in diameter; EDTA: Ethylenediaminetetraacetic acid;
ELISA: Enzyme-linked immunosorbent assay; HPLC-ECD: High performance
liquid chromatography with electrochemical detection; LOD: Level of
detection; SHS: Second-hand smoke; BMI: Body mass index; SD: Standard
deviation; GM: Geometric mean; GSD: Geometric standard deviation.
Competing interests
The authors declare no competing financial or non-financial interests.
Authors’ contributions
AMN was responsible for analysis and interpretation of data and writing
the manuscript. JEH assisted with design, data acquisition, analysis, and
manuscript preparation. JC assisted with data acquisition and interpretation
of data. TJS was involved in the study design and interpretation of data.
DWD assisted with analysis, data interpretation and manuscript preparation.
BAC assisted with analysis and data interpretation. EG was involved in study
design and manuscript preparation. FL made contributions in conception,
design, analysis and drafting the manuscript. All authors read and approved
the final manuscript.
Acknowledgments
We thank Junfeng (Jim) Zhang, Marina J. Canner, Miguel Craig, Monica
Zigman and William Roache for their contributions in the study.
The study was supported by the National Institute of Health/National
Institute of Environmental Health Sciences grants R01 ES016284 and
ES000002.
Neophytou et al. Environmental Health 2013, 12:105 Page 9 of 10
http://www.ehjournal.net/content/12/1/105Author details
1Exposure Epidemiology and Risk Program, Department of Environmental
Health, Harvard School of Public Heath, Boston, MA, USA. 2Channing Division
of Network Medicine, Brigham and Women’s Hospital and Harvard Medical
School, Boston, MA, USA. 3Division of Occupational and Environmental
Medicine, University of Connecticut Health Center, Farmington, CT, USA.
4Department of Biostatistics, Harvard School of Public Health, Boston, MA,
USA. 5VA Boston Healthcare System, West Roxbury, MA, USA.
Received: 3 July 2013 Accepted: 4 December 2013
Published: 7 December 2013
References
1. Brook RD, Rajagopalan S, Pope CA 3rd, Brook JR, Bhatnagar A, Diez-Roux AV,
Holguin F, Hong Y, Luepker RV, Mittleman MA, Peters A, Siscovick D, Smith
SC Jr, Whitsel L, Kaufman JD, American Heart Association Council on
Epidemiology and Prevention, Council on the Kidney in Cardiovascular
Disease, and Council on Nutrition, Physical Activity and Metabolism:
Particulate matter air pollution and cardiovascular disease: an update to
the scientific statement from the American heart association. Circulation
2010, 121:2331–2378.
2. Dockery DW, Luttmann-Gibson H, Rich DQ, Link MS, Mittleman MA, Gold
DR, Koutrakis P, Schwartz J, Verrier RL: Association of air pollution with
increased incidence of ventricular tachyarrhythmias recorded by
implanted cardioverter defibrillators. Environ Health Perspect 2005,
113:670–674.
3. Peters A, Dockery DW, Muller JE, Mittleman MA: Increased particulate air
pollution and the triggering of myocardial infarction. Circulation 2001,
103:2810–2815.
4. Peters A, von Klot S, Heier M, Trentinaglia I, Hormann A, Wichmann HE,
Löwel H, Cooperative Health Research in the Region of Augsburg Study
Group: Exposure to traffic and the onset of myocardial infarction. N Engl
J Med 2004, 351:1721–1730.
5. Pope CA 3rd, Burnett RT, Thurston GD, Thun MJ, Calle EE, Krewski D,
Godleski JJ: Cardiovascular mortality and long-term exposure to
particulate air pollution: epidemiological evidence of general
pathophysiological pathways of disease. Circulation 2004, 109:71–77.
6. Rich DQ, Kim MH, Turner JR, Mittleman MA, Schwartz J, Catalano PJ,
Dockery DW: Association of ventricular arrhythmias detected by
implantable cardioverter defibrillator and ambient air pollutants in Saint
Louis, Missouri. Occup Environ Med 2006, 63:591–596.
7. Rich DQ, Schwartz J, Mittleman MA, Link M, Luttmann-Gibson H, Catalano
PJ, Speizer FE, Dockery DW: Association of short-term ambient air
pollution concentrations and ventricular arrhythmias. Am J Epidemiol
2005, 161:1123–1132.
8. Bigert C, Gustavsson P, Hallqvist J, Hogstedt C, Lewne M, Plato N, Reuterwall
C, Schéele P: Myocardial infarction among professional drivers.
Epidemiology 2003, 14:333–339.
9. Gustavsson P, Plato N, Hallqvist J, Hogstedt C, Lewne M, Reuterwall C,
Schéele P: A population-based case-referent study of myocardial
infarction and occupational exposure to motor exhaust, other
combustion products, organic solvents, lead, and dynamite. Stockholm
Heart Epidemiology Program (SHEEP) Study Group. Epidemiology 2001,
12:222–228.
10. Hart JE, Garshick E, Smith TJ, Davis ME, Laden F: Ischaemic heart disease
mortality and years of work in trucking industry workers. Occup Environ
Med 2012 [Epub ahead of print].
11. Davis ME, Smith TJ, Laden F, Hart JE, Ryan LM, Garshick E: Modeling particle
exposure in US trucking terminals. Environ Sci Technol 2006, 40:4226–4232.
12. Smith TJ, Davis ME, Reaser P, Natkin J, Hart JE, Laden F, Heft A, Garshick E:
Overview of particulate exposures in the US trucking industry. J Environ
Monit 2006, 8:711–720.
13. Chuang KJ, Chan CC, Su TC, Lee CT, Tang CS: The effect of urban air
pollution on inflammation, oxidative stress, coagulation, and autonomic
dysfunction in young adults. Am J Respir Crit Care Med 2007, 176:370–376.
14. Gurgueira SA, Lawrence J, Coull B, Krishna Murthy GG, González-Flecha B:
Rapid increases in the steady-state concentration of reactive oxygen
species in the lungs and heart after particulate air pollution inhalation.
Environ Health Perspect 2002, 110:749–755.
15. Ren C, Fang S, Wright RO, Suh H, Schwartz J: Urinary 8-hydroxy-2′-
deoxyguanosine as a biomarker of oxidative DNA damage induced byambient pollution in the Normative Aging Study. Occup Environ Med
2011, 68:562–569.
16. Rückerl R, Greven S, Ljungman P, Aalto P, Antoniades C, Bellander T,
Berglind N, Chrysohoou C, Forastiere F, Jacquemin B, von Klot S, Koenig W,
Küchenhoff H, Lanki T, Pekkanen J, Perucci CA, Schneider A, Sunyer J, Peters
A, AIRGENE Study Group: Air pollution and inflammation (interleukin-6,
C-reactive protein, fibrinogen) in myocardial infarction survivors.
Environ Health Perspect 2007, 115:1072–1080.
17. Salvi S, Blomberg A, Rudell B, Kelly F, Sandstrom T, Holgate ST, Frew A:
Acute inflammatory responses in the airways and peripheral blood after
short-term exposure to diesel exhaust in healthy human volunteers.
Am J Respir Crit Care Med 1999, 159:702–709.
18. Schwartz J: Air pollution and blood markers of cardiovascular risk.
Environ Health Perspect 2001, 109(Suppl 3):405–409.
19. van Eeden SF, Tan W, Suwa T, Mukae H, Terashima T, Fujii T, Qui D,
Vincent R, Hogg JC: Cytokines involved in the systemic inflammatory
response induced by exposure to particulate matter air pollutants
(PM(10)). Am J Respir Crit Care Med 2001, 164:826–830.
20. Zeka A, Sullivan JR, Vokonas PS, Sparrow D, Schwartz J: Inflammatory
markers and particulate air pollution: characterizing the pathway to
disease. Int J Epidemiol 2006, 35:1347–1354.
21. Alexeeff SE, Coull BA, Gryparis A, Suh H, Sparrow D, Vokonas PS, Schwartz J:
Medium-term exposure to traffic-related air pollution and markers of
inflammation and endothelial function. Environ Health Perspect 2011,
119:481–486.
22. de Lemos JA, Hennekens CH, Ridker PM: Plasma concentration of soluble
vascular cell adhesion molecule-1 and subsequent cardiovascular risk.
J Am Coll Cardiol 2000, 36:423–426.
23. Luc G, Arveiler D, Evans A, Amouyel P, Ferrieres J, Bard JM, Elkhalil L,
Fruchart JC, Ducimetiere P, PRIME Study Group: Circulating soluble
adhesion molecules ICAM-1 and VCAM-1 and incident coronary heart
disease: the PRIME Study. Atherosclerosis 2003, 170:169–176.
24. Pradhan AD, Rifai N, Ridker PM: Soluble intercellular adhesion
molecule-1, soluble vascular adhesion molecule-1, and the
development of symptomatic peripheral arterial disease in men.
Circulation 2002, 106:820–825.
25. Pradhan AD, Manson JE, Rossouw JE, Siscovick DS, Mouton CP, Rifai N,
Wallace RB, Jackson RD, Pettinger MB, Ridker PM: Inflammatory biomarkers,
hormone replacement therapy, and incident coronary heart disease:
prospective analysis from the Women’s Health Initiative observational
study. JAMA 2002, 288:980–987.
26. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR: Comparison of C-reactive
protein and low-density lipoprotein cholesterol levels in the prediction
of first cardiovascular events. N Engl J Med 2002, 347:1557–1565.
27. Peters A, Frohlich M, Doring A, Immervoll T, Wichmann HE, Hutchinson WL,
Pepys MB, Koenig W: Particulate air pollution is associated with an acute
phase response in men; results from the MONICA-Augsburg Study.
Eur Heart J 2001, 22:1198–1204.
28. Rückerl R, Ibald-Mulli A, Koenig W, Schneider A, Woelke G, Cyrys J, Heinrich
J, Marder V, Frampton M, Wichmann HE, Peters A: Air pollution and
markers of inflammation and coagulation in patients with coronary heart
disease. Am J Respir Crit Care Med 2006, 173:432–441.
29. Il’yasova D, Colbert LH, Harris TB, Newman AB, Bauer DC, Satterfield S,
Kritchevsky SB: Circulating levels of inflammatory markers and cancer risk
in the health aging and body composition cohort. Cancer Epidemiol
Biomarkers Prev 2005, 14:2413–2418.
30. Siemes C, Visser LE, Coebergh JW, Splinter TA, Witteman JC, Uitterlinden AG,
Hofman A, Pols HA, Stricker BH: C-reactive protein levels, variation in the
C-reactive protein gene, and cancer risk: the Rotterdam study. J Clin
Oncol 2006, 24:5216–5222.
31. Lagorio S, Tagesson C, Forastiere F, Iavarone I, Axelson O, Carer A: Exposure
tobenzene and urinary concentrations of 8-hydroxydeoxyguanosine, a
biological marker of oxidative damage to DNA. Occup Environ Med 1994,
51:739–743.
32. Kim JY, Mukherjee S, Ngo LC, Christiani DC: Urinary 8-Hydroxy-2′-
Deoxyguanosine as a biomarker of oxidative DNA damage in workers
exposed to fine particulates. Environ Health Perspect 2004, 112:666–671.
33. Ren C, Vokonas PS, Suh H, Fang S, Christiani DC, Schwartz J: Effect
modification of air pollution on urinary 8-Hydroxy-2′-Deoxyguanosine by
genotypes: an application of the multiple testing procedure to identify
significant SNP interactions. Environ Health 2010, 9:78.
Neophytou et al. Environmental Health 2013, 12:105 Page 10 of 10
http://www.ehjournal.net/content/12/1/10534. NIOSH: Elemental Carbon (Diesel Particulate) 5040. In NIOSH Manual of
Analytical Methods. 4th edition. Edited by Casinelli ME, O’Connor PF. Ohio:
National Institute for Occupational Safety and Health; 1998.
35. Tainio M, Tuomisto JT, Hanninen O, Aarnio P, Koistinen KJ, Jantunen MJ,
Pekkanen J: Health effects caused by primary fine particulate matter
(PM2.5) emitted from buses in the Helsinki metropolitan area, Finland.
Risk Anal 2005, 25:151–160.
36. Yanosky JD, MacIntosh DL: A comparison of four gravimetric fine particle
sampling methods. J Air Waste Manag Assoc 2001, 51:878–884.
37. Pai JK, Curhan GC, Cannuscio CC, Rifai N, Ridker PM, Rimm EB: Stability of
novel plasma markers associated with cardiovascular disease: processing
within 36 hours of specimen collection. Clin Chem 2002, 48:1781–1784.
38. Ferris BG: Epidemiology stamdardization project (American Thoracic
Society). Am Rev Respir Dis 1978, 118:1–120.
39. Igishi T, Hitsuda Y, Kato K, Sako T, Burioka N, Yasuda K, Sano H, Shigeoka Y,
Nakanishi H, Shimizu E: Elevated urinary 8-hydroxydeoxyguanosine, a
biomarker of oxidative stress, and lack of association with antioxidant
vitamins in chronic obstructive pulmonary disease. Respirology 2003,
8:455–460.
40. Pilger A, Germadnik D, Riedel K, Meger-Kossien I, Scherer G, Rüdiger HW:
Longitudinal study of urinary 8-hydroxy-2′deoxyguanosine excretion in
healthy adults. Free Radic Res 2001, 35:273–280.
41. Delfino RJ, Staimer N, Tjoa T, Gillen DL, Polidori A, Arhami M, Kleinman MT,
Vaziri ND, Longhurst J, Sioutas C: Air pollution exposures and circulating
biomarkers of effect in a susceptible population: clues to potential
causal component mixtures and mechanisms. Environ Health Perspect
2009, 117:1232–1238.
42. Dubowsky SD, Suh H, Schwartz J, Coull BA, Gold DR: Diabetes, obesity,
and hypertension may enhance associations between air pollution
and markers of systemic inflammation. Environ Health Perspect 2006,
114:992–998.
43. Forbes LJ, Patel MD, Rudnicka AR, Cook DG, Bush T, Stedman JR, Whincup
PH, Strachan DP, Anderson RH: Chronic exposure to outdoor air pollution
and markers of systemic inflammation. Epidemiology 2009, 20:245–253.
44. Steinvil A, Kordova-Biezuner L, Shapira I, Berliner S, Rogowski O: Short-term
exposure to air pollution and inflammation-sensitive biomarkers.
Environ Res 2008, 106:51–61.
45. Riediker M, Cascio WE, Griggs TR, Herbst MC, Bromberg PA, Neas L,
Williams RW, Devlin RB: Particulate matter exposure in cars is associated
with cardiovascular effects in healthy young men. Am J Respir Crit Care
Med 2004, 169:934–940.
46. Li Y, Rittenhouse-Olson K, Scheider WL, Mu L: Effect of particulate matter
air pollution on C-reactive protein: a review of epidemiologic studies.
Rev Environ Health 2012, 27:133–149.
47. Bind MA, Baccarelli A, Zanobetti A, Tarantini L, Suh H, Vokonas P, Schwartz J:
Air pollution and markers of coagulation, inflammation, and endothelial
function. Epidemiology 2012, 23:332–340.
48. Stenfors N, Nordenhäll C, Salvi SS, Mudway I, Söderberg M, Blomberg A,
Helleday R, Levin JO, Holgate ST, Kelly FJ, Frew AJ, Sandström T: Different
airway inflammatory responses in asthmatic and healthy humans
exposed to diesel. Eur Respir J 2004, 23:82–86.
49. Madrigano J, Baccarelli A, Wright RO, Suh H, Sparrow D, Vokonas PS,
Schwartz J: Air pollution, obesity, genes and cellular adhesion molecules.
Occup Environ Med 2010, 67:312–317.
50. Wang Y, Hopke PK, Rattigan OV, Chalupa DC, Utell MJ: Multiple-year black
carbon measurements and source apprtionement using Delta-C in
Rochester, New York. J Air Waste Manag Assoc 2012, 62:880–887.
51. Davis ME, Hart JE, Laden F, Garshick E, Smith TJ: A retrospective
assessment of occupational exposure to elemental carbon in the U.S.
trucking industry. Environ Health Perspect 2011, 119:997–1002.
doi:10.1186/1476-069X-12-105
Cite this article as: Neophytou et al.: Traffic-related exposures and
biomarkers of systemic inflammation, endothelial activation and
oxidative stress: a panel study in the US trucking industry. Environmental
Health 2013 12:105.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
